Cargando…

Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy

PURPOSE: Central serous chorioretinopathy (CSCR) is a complex ocular entity that, in its chronic form, can lead to serious visual impairment and morphological damage to the retina. The aim of the current retrospective study was to evaluate the damage present after long-standing but resolved central...

Descripción completa

Detalles Bibliográficos
Autores principales: Gawęcki, Maciej, Jaszczuk-Maciejewska, Agnieszka, Jurska-Jaśko, Anna, Kneba, Małgorzata, Grzybowski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659242/
https://www.ncbi.nlm.nih.gov/pubmed/31345183
http://dx.doi.org/10.1186/s12886-019-1171-5
_version_ 1783439096114315264
author Gawęcki, Maciej
Jaszczuk-Maciejewska, Agnieszka
Jurska-Jaśko, Anna
Kneba, Małgorzata
Grzybowski, Andrzej
author_facet Gawęcki, Maciej
Jaszczuk-Maciejewska, Agnieszka
Jurska-Jaśko, Anna
Kneba, Małgorzata
Grzybowski, Andrzej
author_sort Gawęcki, Maciej
collection PubMed
description PURPOSE: Central serous chorioretinopathy (CSCR) is a complex ocular entity that, in its chronic form, can lead to serious visual impairment and morphological damage to the retina. The aim of the current retrospective study was to evaluate the damage present after long-standing but resolved central serous chorioretinopathy and refer it to healthy individuals. Correlations between measurable factors—for example, duration of the disease, baseline retinal morphological parameters, or patient age and/or their degree of impairment—were also assessed. MATERIALS AND METHODS: The study group consisted of thirty-two eyes (13 female and 19 male, mean age 49.6 years SD +/− 10.5) with chronic central serous chorioretinopathy (mean duration 18.9 months SD +/− 15.4) in which complete resolution of subretinal fluid was achieved after subthreshold micropulse laser treatment. Inclusion criterion was a lack of subretinal fluid within the whole area of the central retina scanned by the spectral domain optical coherence tomography. The group was extracted out of 51 cases of chronic CSCR that were treated with that method. They were analyzed according to final best-corrected visual acuity and retinal morphological parameters as measured by spectral optical coherence tomography with angiography option (OCTA). Results were compared with the outcomes of a control group, which consisted of 40 eyes of healthy individuals with full distance visual acuity (0.0 logMAR, 1.0 Snellen) never treated with subthreshold micropulse laser. Statistical analysis included regarding correlation between final visual acuity and final central retinal thickness and retinal and functional parameters prior to treatment. RESULTS: Final best-corrected visual acuity after chronic central serous chorioretinopathy was 0.23 logMAR (0.6 Snellen) and central retinal thickness was 39.32 μm smaller than in controls. No correlation was found between final visual acuity and retinal thickness and duration of the disease, patient age, and baseline morphological retinal parameters. OCTA scans revealed impaired choriocapillaries flow signal even following resolution of the disease. CONCLUSION: Chronic central serous chorioretinopathy is a potentially damaging clinical entity that results in serious visual impairment, retinal thinning, and choroidal flow defects. Further research is needed to determine precisely the timepoint of this damage.
format Online
Article
Text
id pubmed-6659242
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66592422019-08-01 Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy Gawęcki, Maciej Jaszczuk-Maciejewska, Agnieszka Jurska-Jaśko, Anna Kneba, Małgorzata Grzybowski, Andrzej BMC Ophthalmol Research Article PURPOSE: Central serous chorioretinopathy (CSCR) is a complex ocular entity that, in its chronic form, can lead to serious visual impairment and morphological damage to the retina. The aim of the current retrospective study was to evaluate the damage present after long-standing but resolved central serous chorioretinopathy and refer it to healthy individuals. Correlations between measurable factors—for example, duration of the disease, baseline retinal morphological parameters, or patient age and/or their degree of impairment—were also assessed. MATERIALS AND METHODS: The study group consisted of thirty-two eyes (13 female and 19 male, mean age 49.6 years SD +/− 10.5) with chronic central serous chorioretinopathy (mean duration 18.9 months SD +/− 15.4) in which complete resolution of subretinal fluid was achieved after subthreshold micropulse laser treatment. Inclusion criterion was a lack of subretinal fluid within the whole area of the central retina scanned by the spectral domain optical coherence tomography. The group was extracted out of 51 cases of chronic CSCR that were treated with that method. They were analyzed according to final best-corrected visual acuity and retinal morphological parameters as measured by spectral optical coherence tomography with angiography option (OCTA). Results were compared with the outcomes of a control group, which consisted of 40 eyes of healthy individuals with full distance visual acuity (0.0 logMAR, 1.0 Snellen) never treated with subthreshold micropulse laser. Statistical analysis included regarding correlation between final visual acuity and final central retinal thickness and retinal and functional parameters prior to treatment. RESULTS: Final best-corrected visual acuity after chronic central serous chorioretinopathy was 0.23 logMAR (0.6 Snellen) and central retinal thickness was 39.32 μm smaller than in controls. No correlation was found between final visual acuity and retinal thickness and duration of the disease, patient age, and baseline morphological retinal parameters. OCTA scans revealed impaired choriocapillaries flow signal even following resolution of the disease. CONCLUSION: Chronic central serous chorioretinopathy is a potentially damaging clinical entity that results in serious visual impairment, retinal thinning, and choroidal flow defects. Further research is needed to determine precisely the timepoint of this damage. BioMed Central 2019-07-25 /pmc/articles/PMC6659242/ /pubmed/31345183 http://dx.doi.org/10.1186/s12886-019-1171-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gawęcki, Maciej
Jaszczuk-Maciejewska, Agnieszka
Jurska-Jaśko, Anna
Kneba, Małgorzata
Grzybowski, Andrzej
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
title Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
title_full Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
title_fullStr Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
title_full_unstemmed Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
title_short Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
title_sort impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659242/
https://www.ncbi.nlm.nih.gov/pubmed/31345183
http://dx.doi.org/10.1186/s12886-019-1171-5
work_keys_str_mv AT gaweckimaciej impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy
AT jaszczukmaciejewskaagnieszka impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy
AT jurskajaskoanna impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy
AT knebamałgorzata impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy
AT grzybowskiandrzej impairmentofvisualacuityandretinalmorphologyfollowingresolvedchroniccentralserouschorioretinopathy